NCT03132532View on ClinicalTrials.gov

Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

December 23, 2023

Study Completion Date

December 23, 2023

Conditions
Recurrent Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Unresectable Lung Non-Small Cell Carcinoma
Interventions
DRUG

Carboplatin

Chemotherapy

DRUG

Cisplatin

Chemotherapy

DRUG

Etoposide

Chemotherapy

DRUG

Paclitaxel

Chemotherapy

DRUG

Pemetrexed

Chemotherapy

RADIATION

Proton Beam Radiation Therapy

Undergo PBT

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (2)

55905

Mayo Clinic in Rochester, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER